Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Charles F Jr Wagner
Charles F Jr Wagner is EVP, CO & FO at Vertex Pharmaceuticals. OQRO lists 16 transactions filed with the SEC under this name, the latest on Jun 11, 2026, each linked to the official Form 4.
EVP, CO & FO
Disclosures on record
16
Companies involved
2
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$4.39M of Vertex Pharmaceuticals
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$3.23M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$3.16M of Vertex Pharmaceuticals
Scheduled in advance